Curi Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Curi Wealth Management's ARKG Position: Q3 2022 in Review
Curi Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 159 shares — an estimated $5K sold.
Curi Wealth Management first reported a position in ARKG in Q4 2020 and held it in 4 quarters. The position peaked at $9K in Q4 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.
- Curi Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
- Curi Wealth Management sold 159 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $5K.
- Curi Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 4 quarters.
- Curi Wealth Management's ARK Genomic Revolution ETF position peaked at $9K in Q4 2021.
- 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.
Based on Curi Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.